007 Immunotherapy responsive neuropathic pain associated with LGI1 and CASPR2 antibodies

• Russell C Dale,
• Simon Rinaldi,
• Sophia Michael,
• David Bennett,
• James Varley,
• Yaacov Anziska,
• Monika Hofer,
• Sudarshini Ramanathan,
• Fabienne Brilot,
• Alexander Davies,
• Mandy Tseng,
• Sofija Paneva,
• Andreas Themistocleous,
• Ana Candalija,
• John Dawes

Affiliations

Russell C Dale

10 Neuroimmunology Group, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia

Simon Rinaldi

Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK

Sophia Michael

Department of Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK

David Bennett

5 Section of Pneumology, COVID-19 Unit, Siena University Hospital, Siena, Toscana, Italy

James Varley

3 Department of Neurology, Imperial College Healthcare NHS Trust, London, UK

Yaacov Anziska

2University of Oxford, Oxford, UK

Monika Hofer

22 Department of Neuropathology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Sudarshini Ramanathan

1 Brain Autoimmunity Group, Institute for Neuroscience and Muscle Research, The Kids Research Institute at the Children’s Hospital, Westmead, New South Wales, Australia

Fabienne Brilot

1 Brain Autoimmunity Group, Institute for Neuroscience and Muscle Research, The Kids Research Institute at the Children’s Hospital, Westmead, New South Wales, Australia

Alexander Davies

2University of Oxford, Oxford, UK

Mandy Tseng

2University of Oxford, Oxford, UK

Sofija Paneva

2University of Oxford, Oxford, UK

Andreas Themistocleous

2University of Oxford, Oxford, UK

Ana Candalija

2University of Oxford, Oxford, UK

John Dawes

2University of Oxford, Oxford, UK